Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

• Published in: Aging cell 2019-12, Vol.18 (6), p.e13031-n/a
• Main Authors: Trist, Benjamin G., Hare, Dominic J., Double, Kay L.
• Format: Article
• Language: English
• Subjects: Aging; Aging - metabolism; Animals; antioxidant; Calcium - metabolism; Causes and theories of causation; Cell death; Cellular Senescence; Development and progression; Diseases; Dopamine; Dopamine receptors; Etiology; Humans; Mitochondria - metabolism; Mitochondria - pathology; Movement disorders; Neurodegenerative diseases; Neurons; Neurophysiology; Neurotransmission; Oxidative Stress; Parkinson Disease - etiology; Parkinson Disease - metabolism; Parkinson Disease - pathology; Parkinson's disease; reactive oxygen species; Review; Reviews; Substantia nigra; Substantia Nigra - metabolism; Substantia Nigra - pathology
• ISSN: 1474-9718; 1474-9726
• DOI: 10.1111/acel.13031

Parkinson's disease prevalence is rapidly increasing in an aging global population. With this increase comes exponentially rising social and economic costs, emphasizing the immediate need for effective disease‐modifying treatments. Motor dysfunction results from the loss of dopaminergic neurons in the substantia nigra pars compacta and depletion of dopamine in the nigrostriatal pathway. While a specific biochemical mechanism remains elusive, oxidative stress plays an undeniable role in a complex and progressive neurodegenerative cascade. This review will explore the molecular factors that contribute to the high steady‐state of oxidative stress in the healthy substantia nigra during aging, and how this chemical environment renders neurons susceptible to oxidative damage in Parkinson's disease. Contributing factors to oxidative stress during aging and as a pathogenic mechanism for Parkinson's disease will be discussed within the context of how and why therapeutic approaches targeting cellular redox activity in this disorder have, to date, yielded little therapeutic benefit. We present a contemporary perspective on the central biochemical contribution of redox imbalance to Parkinson's disease etiology and argue that improving our ability to accurately measure oxidative stress, dopaminergic neurotransmission and cell death pathways in vivo is crucial for both the development of new therapies and the identification of novel disease biomarkers. Dopamine neurons within the healthy human substantia nigra exhibit mild oxidative stress during aging, resulting from their unique biochemical properties and a number of age‐dependent biochemical changes specific to this neuronal population (grey). An exacerbation of these pathways, combined with additional environmental toxins and genetic mutations, worsens redox balance within nigral dopamine neurons in Parkinson's disease, causing excessive oxidative stress and dopamine neuron death (red).